Get ready to discover the eagerly anticipated third quarter financial results of Quest Diagnostics (NYSE: DGX) on Tuesday 22nd October 2024. This significant announcement is scheduled to take place before market open, giving investors and analysts a chance to gain valuable insights into the company's financial performance.
Wall Street financial analysts are foreseeing that the enterprise is likely to announce an estimated per share $2.26 profit for the quarter. Furthermore, it is anticipated that the company will disclose a total revenue of $2.42 billion during the quarter.
The per-share income of $2.22 was highlighted in the company's earnings report for the same quarter of the prior year. This notable figure was achieved due to the company's impressive total revenue of $2.3 billion recorded during that specific period.
The company's full-year performance has been analyzed by wall street analysts, who have shared their projections. According to the analysis, it is expected that the company will generate a total revenue of $9.67 billion. Additionally, the earnings per share for the company are also anticipated to reach profit of $8.85 over the course of the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $2.35 | +2.2% | 2.40 B | +2.5% |
| Q1 2024 | $2.04 | 0% | 2.37 B | +1.5% |
| Q4 2023 | $2.15 | +8.6% | 2.29 B | -1.9% |
| Q3 2023 | $2.22 | -5.9% | 2.30 B | -7.7% |
| Q2 2023 | $2.30 | -2.5% | 2.34 B | -4.7% |
| *Growth on year-over-year basis | ||||
The business has scheduled a conference call on 22nd October 2024 at 08:30 AM eastern time to discuss Q3 financial results.
Quest Diagnostics (DGX) closed Friday's regular trading session at $149.65, reflecting a 0.46 percent upturn. During the day, DGX shares traded between $147.96 and $150.59, with a day volume of 631.40 thousand shares.